Position
Chief Business Officer
Company
CHARM Therapeutics
LondonBiotechnologyHealthcareHealth CareDescription
CHARM Therapeutics appoints Dr Beverley Carr as Chief Business Officer. Highly experienced dealmaker to lead CHARM’s business development and drive strategic value from CHARM’s leading protein-ligand intelligence platform.
Quick answer
CHARM Therapeutics Appoints Dr Beverley Carr as Chief Business Officer (September 10, 2024). CHARM Therapeutics is based in London, England, United Kingdom.
- Who is the new Chief Business Officer at CHARM Therapeutics?
- CHARM Therapeutics named Beverley Carr Chief Business Officer, announced September 10, 2024.
- What did CHARM Therapeutics announce on September 10, 2024?
- CHARM Therapeutics appoints Dr Beverley Carr as Chief Business Officer. Highly experienced dealmaker to lead CHARM’s business development and drive strategic value from CHARM’s leading protein-ligand intelligence platform.
- What does CHARM Therapeutics do?
- CHARM Therapeutics is discovering and developing small molecule medicines against difficult-to-drug targets with our proprietary 3D deep learning-enabled platform, DragonFold.
- Where is CHARM Therapeutics based?
- CHARM Therapeutics is based in London, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- ReAlta Life Sciences (September 4, 2024), Insightec (September 3, 2024), Tenon Medical (August 27, 2024) and Climb Bio, Inc. (August 26, 2024) also announced leadership changes within 45 days of CHARM Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- ReAlta Life Sciences Appoints Peter Ho, Ph.D., as Head of Business Development and Corporate Strategy (September 4, 2024)
- Insightec Appoints Jake Ghannam as Chief Commercial Officer (September 3, 2024)
- Tenon Medical Appoints Kevin Williamson as Chief Financial Officer (August 27, 2024)
- Eliem Therapeutics Appoints Brett Kaplan, M.D. as Chief Operating Officer and Nishi Rampal, M.D. as Senior Vice President, Clinical Development (August 26, 2024)
- Century Therapeutics appoints Morgan Conn as Chief Financial Officer and Chad Cowen as Chief Scientific Officer (September 27, 2024)
- Nuvation Bio Appoints Philippe Sauvage as Chief Financial Officer (October 7, 2024)
Who to call at CHARM Therapeutics, and when
A new leader at CHARM Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day CHARM Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CHARM Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CHARM Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CHARM Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CHARM Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.